We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSM
1401
PUT
DELISTED
Versum Materials, Inc.
VSM
$10K ﹤0.01%
+200
New +$10.3K
ADAP
1402
DELISTED
Adaptimmune Therapeutics
ADAP
$9K ﹤0.01%
2,204
+1,385
+169% +$5.65K
AMRX icon
1403
Amneal Pharmaceuticals
AMRX
$5.77B
$9K ﹤0.01%
+1,300
New +$13.3K
ARAY icon
1404
Accuray
ARAY
$33.8M
$9K ﹤0.01%
+2,305
New +$9.31K
AUTL
1405
Autolus Therapeutics
AUTL
$532M
$9K ﹤0.01%
590
+203
+52% +$4.54K
BAH icon
1406
Booz Allen Hamilton
BAH
$8.89B
$9K ﹤0.01%
142
-103
-42% -$6.33K
CMCM
1407
Cheetah Mobile
CMCM
$101M
$9K ﹤0.01%
+515
New +$13.5K
CRMT icon
1408
America's Car Mart
CRMT
$27.5M
$9K ﹤0.01%
+108
New +$9.94K
EVR icon
1409
Evercore
EVR
$12B
$9K ﹤0.01%
+105
New +$9.35K
FORM icon
1410
FormFactor
FORM
$9B
$9K ﹤0.01%
+600
New +$9.82K
IDT icon
1411
IDT Corp
IDT
$1.65B
$9K ﹤0.01%
937
-14,013
-94% -$103K
KDP icon
1412
CALL
Keurig Dr Pepper
KDP
$41.3B
$9K ﹤0.01%
300
KPTI icon
1413
Karyopharm Therapeutics
KPTI
$44.2M
$9K ﹤0.01%
102
+81
+386% +$6.5K
SIGA icon
1414
SIGA Technologies
SIGA
$224M
$9K ﹤0.01%
+1,567
New +$8.68K
XERS icon
1415
Xeris Biopharma Holdings
XERS
$1.27B
$9K ﹤0.01%
+757
New +$7.95K
TUP
1416
DELISTED
Tupperware Brands Corporation
TUP
$9K ﹤0.01%
+458
New +$10.3K
SECO
1417
DELISTED
Secoo Holding Limited ADR
SECO
$9K ﹤0.01%
+125
New +$10.8K
SFUN
1418
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$9K ﹤0.01%
+282
New +$17.8K
TNAV
1419
DELISTED
Telenav Inc.
TNAV
$9K ﹤0.01%
1,069
+769
+256% +$5.36K
AMAG
1420
DELISTED
AMAG Pharmaceuticals
AMAG
$9K ﹤0.01%
+897
New +$9.68K
MDSO
1421
PUT
DELISTED
Medidata Solutions, Inc.
MDSO
$9K ﹤0.01%
+100
New +$8.78K
CYD icon
1422
China Yuchai International
CYD
$1.83B
$8K ﹤0.01%
+518
New +$7.99K
INCY icon
1423
CALL
Incyte
INCY
$24B
$8K ﹤0.01%
+100
New +$8.03K
MLM icon
1424
Martin Marietta Materials
MLM
$32.3B
$8K ﹤0.01%
+35
New +$7.58K
MTD icon
1425
Mettler-Toledo International
MTD
$28.5B
$8K ﹤0.01%
+9
New +$6.79K

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.